Cargando…

Targeting GLI1 Transcription Factor for Restoring Iodine Avidity with Redifferentiation in Radioactive-Iodine Refractory Thyroid Cancers

SIMPLE SUMMARY: Thyroid cancers have an excellent prognosis by standard therapy of surgery followed by radioactive-iodine therapy. However, metastatic thyroid cancers do not response to radioactive-iodine therapy by losing iodine avidity. Therefore, reversing iodine avidity to metastatic thyroid can...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oh, Ji Min, Rajendran, Ramya Lakshmi, Gangadaran, Prakash, Hong, Chae Moon, Jeong, Ju Hye, Lee, Jaetae, Ahn, Byeong-Cheol
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997411/ https://www.ncbi.nlm.nih.gov/pubmed/35406554 http://dx.doi.org/10.3390/cancers14071782

Ejemplares similares

Reverting iodine avidity of radioactive-iodine refractory thyroid cancer with a new tyrosine kinase inhibitor (K905-0266) excavated by high-throughput NIS (sodium iodide symporter) enhancer screening platform using dual reporter gene system
por: Oh, Ji Min, et al.
Publicado: (2018)

Extracellular Vesicles Act as Nano-Transporters of Tyrosine Kinase Inhibitors to Revert Iodine Avidity in Thyroid Cancer
por: Rajendran, Ramya Lakshmi, et al.
Publicado: (2021)

Radioactive Iodine-Refractory Differentiated Thyroid Cancer and Redifferentiation Therapy
por: Liu, Jierui, et al.
Publicado: (2019)

SAT520 Efficacy of Radioactive Iodine Redifferentiation Therapy in Previously Iodine Refractory Differentiated Thyroid Cancers
por: Toro-Tobon, David, et al.
Publicado: (2023)

Radioactive Iodine Resistant Papillary Thyroid Cancer “Redifferentiated” With Dabrafenib
por: Zayouna, Christine, et al.
Publicado: (2021)

The Genomic Landscape of Radioactive Iodine Refractory and Avid Papillary Thyroid Carcinomas
por: Al-Kuraya, Khawla Sami, et al.
Publicado: (2021)

Risk factors for radioactive iodine-avid metastatic lymph nodes on post I-131 ablation SPECT/CT in low- or intermediate-risk groups of papillary thyroid cancer
por: Lee, Chang-Hee, et al.
Publicado: (2018)

Different Expression of Thyroid-Specific Proteins in Thyroid Cancer Cells between 2-Dimensional (2D) and 3-Dimensional (3D) Culture Environment
por: Oh, Ji Min, et al.
Publicado: (2022)

Redifferentiation of Radioiodine Refractory Differentiated Thyroid Cancer for Reapplication of I-131 Therapy
por: Hong, Chae Moon, et al.
Publicado: (2017)

MERAIODE: A Redifferentiation Phase II Trial With Trametinib and Dabrafenib Followed by Radioactive Iodine Administration for Metastatic Radioactive Iodine Refractory Differentiated Thyroid Cancer Patients With a BRAFV600E Mutation (NCT 03244956)
por: Leboulleux, Sophie, et al.
Publicado: (2021)

Application of In Vivo Imaging Techniques for Monitoring Natural Killer Cell Migration and Tumor Infiltration
por: Gangadaran, Prakash, et al.
Publicado: (2020)

Quantitative thyroglobulin response to radioactive iodine treatment in predicting radioactive iodine-refractory thyroid cancer with pulmonary metastasis
por: Wang, Chen, et al.
Publicado: (2017)

A novel strategy of transferring NIS protein to cells using extracellular vesicles leads to increase in iodine uptake and cytotoxicity
por: Son, Seung Hyun, et al.
Publicado: (2019)

Retraction Note: Radiation Sialadenitis Induced by High-dose Radioactive Iodine Therapy
por: Jeong, Shin Young, et al.
Publicado: (2014)

Identification of Radioactive Iodine Refractory Differentiated Thyroid Cancer
por: Mu, Zhuan-Zhuan, et al.
Publicado: (2019)

Development of an athyroid mouse model using (131)I ablation after preparation with a low-iodine diet
por: Oh, Ji Min, et al.
Publicado: (2017)

Identification of Angiogenic Cargo in Extracellular Vesicles Secreted from Human Adipose Tissue-Derived Stem Cells and Induction of Angiogenesis In Vitro and In Vivo
por: Gangadaran, Prakash, et al.
Publicado: (2021)

Application of extracellular vesicles from mesenchymal stem cells promotes hair growth by regulating human dermal cells and follicles
por: Rajendran, Ramya Lakshmi, et al.
Publicado: (2022)

Noninvasive in vivo cell tracking using molecular imaging: A useful tool for developing mesenchymal stem cell-based cancer treatment
por: Rajendran, Ramya Lakshmi, et al.
Publicado: (2020)

Engineered Nanovesicles from Fibroblasts Modulate Dermal Papillae Cells In Vitro and Promote Human Hair Follicle Growth Ex Vivo
por: Rajendran, Ramya Lakshmi, et al.
Publicado: (2022)

Iodine Uptake in Retroperitoneal Cysts after Radioactive Iodine Treatment
por: Lee, Ji Young, et al.
Publicado: (2020)

Treating Hyperthyroidism with Radioactive Iodine
por: Harding, L K
Publicado: (1993)

Radioactive iodine and female fertility
por: Navarro, Pino, et al.
Publicado: (2022)

Sorafenib in radioactive iodine-refractory well-differentiated metastatic thyroid cancer
por: McFarland, Daniel C, et al.
Publicado: (2014)

Radioactive iodine-refractory differentiated thyroid cancer: an uncommon but challenging situation
por: Schmidt, Angelica, et al.
Publicado: (2017)

Molecular mechanisms of radioactive iodine refractoriness in differentiated thyroid cancer: Impaired sodium iodide symporter (NIS) expression owing to altered signaling pathway activity and intracellular localization of NIS
por: Oh, Ji Min, et al.
Publicado: (2021)

Health state utility valuation in radioactive iodine-refractory differentiated thyroid cancer
por: Fordham, Beth A, et al.
Publicado: (2015)

Targeted Treatment Options of Recurrent Radioactive Iodine Refractory Hürthle Cell Cancer
por: Aydemirli, Mehtap Derya, et al.
Publicado: (2019)

Patient-Derived Papillary Thyroid Cancer Organoids for Radioactive Iodine Refractory Screening
por: Sondorp, Luc H.J., et al.
Publicado: (2020)

The efficacy and safety in radioactive iodine refractory thyroid cancer patients treated with sorafenib
por: Ling, Yuanna, et al.
Publicado: (2023)

Insulin pump exposed to radioactive iodine
por: Magdaleno, Angela L., et al.
Publicado: (2018)

Radioactive Iodine Therapy and Glucose Tolerance
por: Samadi, Roghaieh, et al.
Publicado: (2017)

Radioiodine labeling and in vivo trafficking of extracellular vesicles
por: Hong, Chae Moon, et al.
Publicado: (2021)

Interleukin-4 Receptor Targeting Peptide Decorated Extracellular Vesicles as a Platform for In Vivo Drug Delivery to Thyroid Cancer
por: Gangadaran, Prakash, et al.
Publicado: (2022)

CAR T-Cell-Based gene therapy for cancers: new perspectives, challenges, and clinical developments
por: Jogalekar, Manasi P., et al.
Publicado: (2022)

Application of Cell-Derived Extracellular Vesicles and Engineered Nanovesicles for Hair Growth: From Mechanisms to Therapeutics
por: Gangadaran, Prakash, et al.
Publicado: (2022)

Coexisting iodine avid and iodine nonconcentrating lesions with multiple distant soft tissue metastasis in papillary thyroid cancer
por: Mohapatra, Tushar, et al.
Publicado: (2012)

Patient Benefit-Risk Tradeoffs for Radioactive Iodine-Refractory Differentiated Thyroid Cancer Treatments
por: Mohamed, Ateesha F., et al.
Publicado: (2015)

Editorial: Apatinib and Anlotinib in the Treatment of Radioactive Iodine Refractory and Highly Invasive Thyroid Carcinoma
por: Jia, Wenqing, et al.
Publicado: (2022)

Low Iodine Diet for Preparation for Radioactive Iodine Therapy in Differentiated Thyroid Carcinoma in Korea
por: Chung, Jae Hoon
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_1m6a7114bjkj5r51mqm00fr0nv